Paradigm Shift: DOACs for Prevention and Treatment of CAT

Accredited Program Available for Presentations

Program Learning Objectives:

After attending the program, participants will be better able to:

1. Describe the rationale for primary thromboprophylaxis in ambulatory cancer patients
2. Apply data from recent clinical trials in clinical decision-making about primary thromboprophylaxis
3. Discuss direct oral anticoagulants in the treatment of cancer-associated thrombosis (CAT) recognizing cancer subgroups and bleeding risk

Contact us at Info@ThrombosisCanada.ca for a copy of the presentation